Cholesterol-lowering pill sparks scare in Japan after 2 deaths, over 100 hospitalisations
According to a report by news agency Kyodo, there have been two fatalities and over 100 hospitalizations suspected to be
Read moreAccording to a report by news agency Kyodo, there have been two fatalities and over 100 hospitalizations suspected to be
Read moreWipro GE Healthcare on Tuesday said it will invest over Rs 8,000 crore in India over the next five years
Read moreAccording to the projections, the burden of female breast cancer in India in 2025 is expected to be 5.6 million
Read moreThe trials are carried out by Bharat Biotech in close collaboration with Biofabri. Trials to evaluate the safety and immunogenicity
Read moreLondon: The U.S. Food and Drug Administration said on Friday it had granted traditional approval for AbbVie’s “guided missile” cancer
Read moreE lon Musk’s brain-chip startup Neuralink livestreamed on Wednesday its first patient implanted with a chip playing online chess. Noland
Read moreNew Delhi: Cardiologists are advocating for additional research on the drug lecanemab that can add to the limited safety data,
Read more<img class="unveil" loading="eager" src="https://health.economictimes.indiatimes.com/Themes/Release/images/responsive/ethealthworld-default.jpg" data-src="https://etimg.etb2bimg.com/photo/108607755.cms" captionrendered="1" alt=" REUTERS/Amit Dave/File Photo “>REUTERS/Amit Dave/File Photo NEW DELHI: Supreme Court on Tuesday issued
Read moreIndore: The export of pharmaceutical products from Madhya Pradesh has seen a significant increase in the ongoing fiscal year with
Read moreSapporo: A new study has discovered a potential therapy target for immune-related conditions such as multiple sclerosis and asthma. A
Read more